0001168404-16-000038.txt : 20160829 0001168404-16-000038.hdr.sgml : 20160829 20160829171728 ACCESSION NUMBER: 0001168404-16-000038 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160829 DATE AS OF CHANGE: 20160829 EFFECTIVENESS DATE: 20160829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC CENTRAL INDEX KEY: 0001445499 IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-269740 FILM NUMBER: 161858646 BUSINESS ADDRESS: STREET 1: 915 EAST PINE ST STREET 2: SUITE 401 CITY: SEATTLE STATE: WA ZIP: 98122 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 915 EAST PINE ST STREET 2: SUITE 401 CITY: SEATTLE STATE: WA ZIP: 98122 D 1 primary_doc.xml X0707 D LIVE 0001445499 IMPEL NEUROPHARMA INC 915 EAST PINE ST SUITE 401 SEATTLE WA WASHINGTON 98122 206-568-1466 DELAWARE None None Corporation true John D. Hoekman c/o Impel NeuroPharma, Inc. 915 East Pine St., Suite 401 Seattle WA WASHINGTON 98122 Executive Officer Director Stewart Parker c/o Impel NeuroPharma, Inc. 915 East Pine St., Suite 401 Seattle WA WASHINGTON 98122 Director Other Health Care Decline to Disclose 06b false 2016-07-06 false true true true false 0 2000000 1090000 910000 false 4 0 0 0 false IMPEL NEUROPHARMA INC /s/ JOHN HOEKMAN John Hoekman President and CEO 2016-08-29